Abstract 974P
Background
The burgeoning demand for hepatectomy in elderly patients with hepatocellular carcinoma (HCC) necessitates improved perioperative care. Geriatric populations frequently experience functional decline and frailty, predisposing them to adverse postoperative outcomes. The Barthel Index serves as a reliable measure for assessing functional capacity, and this study evaluates its impact on surgical textbook outcomes (TOs) as composite quality indicators following hepatectomy in elderly HCC patients.
Methods
A multicenter retrospective cohort study analyzed elderly patients (≥70 years) who underwent hepatectomy for HCC between 2013 and 2021 at 11 Chinese hospitals. Utilizing a Barthel Index cut-off value of 85, patients were divided into two groups: with and without preoperative functional decline and frailty. The primary outcome was TO, encompassing seven criteria. TO rates were compared between groups, and multivariate logistic regression analyses identified independent risk factors for achieving TOs.
Results
Of 497 elderly HCC patients, 157 (31.6%) exhibited preoperative functional decline and frailty (Barthel Index score <85). The overall TO rate was 58.6%. Patients with preoperative Barthel Index score <85 had significantly lower TO rates compared to patients with preoperative Barthel Index score ≥85 (29.3% vs. 72.1%, P<0.001). Similar differences emerged regarding perioperative blood transfusion, postoperative major morbidity, prolonged hospital stays, 30-day readmission, and 90-day mortality rates. Multivariate analysis revealed preoperative Barthel Index score <85 as an independent risk for achieving TO (odds ratio 3.413, 95% confidence interval 1.879-6.198, P<0.001). Comparable results were observed in subgroup population of patients undergoing open and laparoscopic hepatectomy, respectively.
Conclusions
Preoperative Barthel Index-based assessment of functional decline and frailty significantly predicts TOs following hepatectomy in elderly HCC patients, enabling identification of high-risk patients and informing preoperative management and postoperative care within geriatric oncology.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Tian Yang.
Funding
National Natural Science Foundation of China; Dawn Project Foundation of Shanghai; Shanghai Health Academic Leader Program.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
735P - Causes of death in a complete cohort of testicular cancer patients diagnosed in Norway 1980-2009, with detailed treatment information
Presenter: Øivind Kvammen
Session: Poster session 18
736P - Residual masses after salvage chemotherapy in men with metastatic seminoma: The Semi-ResMass multicenter retrospective study
Presenter: Giulia Baciarello
Session: Poster session 18
737P - Vascular fingerprint tool to identify testicular cancer patients at high-risk for early cardiovascular events after cisplatin-based chemotherapy
Presenter: Andrea Meuleman
Session: Poster session 18
738P - Penile squamous cell carcinoma with high and very high tumor mutational burden (TMB): A genomic landscape and "real-world" clinical outcome study
Presenter: Joseph Jacob
Session: Poster session 18
739P - Penile squamous cell carcinoma tissue associated macrophages captured by multiplex immunfluorence are associated with clinical outcomes
Presenter: Jad Chahoud
Session: Poster session 18
827P - Mutational spectra of the Korean patients with germline predisposition in hematologic malignancies: Five years of experience at a tertiary university hospital
Presenter: In-Suk Kim
Session: Poster session 18
828P - Clinical features and outcomes of neurologic paraneoplastic syndromes in Hodgkin lymphoma
Presenter: Benjamin McCormick
Session: Poster session 18
829P - Age and sex related genomic profiles of follicular lymphoma
Presenter: Robin Imperial
Session: Poster session 18
830P - Isolation of cell-free DNA of patients with mucosa-associated lymphoid tissue (MALT) lymphoma
Presenter: Julia Berger
Session: Poster session 18
831P - Decitabine sensitized TP53-mutated diffuse large B cell lymphoma to R-CHOP treatment via activation of endogenous retrovirus
Presenter: Li Wang
Session: Poster session 18